Product NDC: | 49349-811 |
Proprietary Name: | LEXIVA |
Non Proprietary Name: | fosamprenavir calcium |
Active Ingredient(s): | 700 mg/1 & nbsp; fosamprenavir calcium |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 49349-811 |
Labeler Name: | REMEDYREPACK INC. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021548 |
Marketing Category: | NDA |
Start Marketing Date: | 20130509 |
Package NDC: | 49349-811-02 |
Package Description: | 30 TABLET, FILM COATED in 1 BLISTER PACK (49349-811-02) |
NDC Code | 49349-811-02 |
Proprietary Name | LEXIVA |
Package Description | 30 TABLET, FILM COATED in 1 BLISTER PACK (49349-811-02) |
Product NDC | 49349-811 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | fosamprenavir calcium |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20130509 |
Marketing Category Name | NDA |
Labeler Name | REMEDYREPACK INC. |
Substance Name | FOSAMPRENAVIR CALCIUM |
Strength Number | 700 |
Strength Unit | mg/1 |
Pharmaceutical Classes | HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A4 Inhibitors [MoA] |